Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.

M L Hoefle, S G Hastings, R F Meyer

    Journal of Medicinal Chemistry
    |February 1, 1975
    PubMed
    Summary

    Researchers synthesized novel 1-amino-3-aryloxy-2-propanols for cardioselective beta-blockade. The (3,4-dimethoxyphenethyl)amino group yielded the most selective agents, with one compound chosen for clinical trials.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Determinants of sustainable adoption in primary care of a clinical decision support system for antimicrobial prescribing: A qualitative study.

    Infectious diseases now·2025
    Same author

    Retrospective analysis of the incidence and clinicopathological findings associated with ammonium urate urolithiasis in dogs with congenital portosystemic shunts: 363 cases (2010-2023).

    The Journal of small animal practice·2025
    Same author

    The use of 10% buffered formalin as a preservative agent when cerebrospinal fluid analysis is delayed.

    The Journal of small animal practice·2024
    Same author

    Drug-resistant TB in Morobe Province, Papua New Guinea, 2012-2021.

    Public health action·2024
    Same author

    Women attending the sexual assault treatment unit services in the Republic of Ireland: A 7-year review.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2024
    Same author

    Operational research highlights ongoing challenges for comprehensive TB services in Papua New Guinea.

    Public health action·2024

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology

    Background:

    • Cardioselective beta-blockers are crucial for managing cardiovascular diseases.
    • Developing agents with improved selectivity and potency remains an ongoing challenge.

    Purpose of the Study:

    • To synthesize and evaluate a series of 1-amino-3-aryloxy-2-propanols for cardioselective beta-blockade.
    • To identify structure-activity relationships governing beta-blocker activity and selectivity.

    Main Methods:

    • Chemical synthesis of novel 1-amino-3-aryloxy-2-propanol derivatives.
    • Pharmacological evaluation of synthesized compounds for beta-adrenergic receptor blockade.
    • Analysis of structure-activity relationships to correlate chemical modifications with biological activity.

    Main Results:

    Related Experiment Videos

    • Several synthesized compounds exhibited beta-adrenergic blocking activity.
    • Introduction of the (3,4-dimethoxyphenethyl)amino group resulted in the most cardioselective agents.
    • 1-[(3,4-dimethoxyphenethyl)amino]-3-(m-tolyloxy)-2-propanol demonstrated optimal potency and selectivity.

    Conclusions:

    • The (3,4-dimethoxyphenethyl)amino moiety is key for achieving high cardioselectivity in this series of compounds.
    • 1-[(3,4-dimethoxyphenethyl)amino]-3-(m-tolyloxy)-2-propanol is a promising candidate for further clinical investigation as a cardioselective beta-blocker.